Dimitrios T Boumpas (Dimitrios Boumpas)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 74

Top Venues

Annals of the rheumatic diseases

RMD open

Lupus science & medicine

Rheumatology international

Univeristy of Athens Medical School

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Univeristy of Athens Medical School Apr 15 2012

Greece

Professor Director :: Medicine

Publications

Myrto Kostopoulou, Chetan B Mukhtyar, George K Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations. Annals of the rheumatic diseases (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Dionysis S Nikolopoulos, Catherine Loukogiannaki, George Sentis, Panagiotis Garantziotis, Theodora Manolakou, Noemin Kapsala, Myrto Nikoloudaki, Antigone Pieta, Sofia Flouda, Ioannis Parodis, George K Bertsias, Antonis Fanouriakis, Anastasia Filia, Dimitrios T Boumpas
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Annals of the rheumatic diseases (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
Eleni Zervopoulou, Maria Grigoriou, Stavros A Doumas, Danae Yiannakou, Pavlos Pavlidis, Gilles Gasparoni, Jörn Walter, Anastasia Filia, Harikleia Gakiopoulou, Aggelos Banos, Ioannis Mitroulis, Dimitrios T Boumpas
Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis. Lupus science & medicine 11 (1) (2024)
Eleni Zervopoulou, Maria Grigoriou, Stavros A Doumas, Danae Yiannakou, Pavlos Pavlidis, Gilles Gasparoni, Jörn Walter, Anastasia Filia, Harikleia Gakiopoulou, Aggelos Banos, Ioannis Mitroulis, Dimitrios T Boumpas
Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis. Lupus science & medicine 11 (1) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Maria Pappa, Maria Kosmetatou, Antigone Pieta, Myrto Nikoloudaki, Nektarios Marios Liapis, Christina Tsalapaki, Aglaia Chalkia, Evangelia Argyriou, Theodoros Dimitroulas, Myrto Cheila, Georgios Demirtzoglou, Charalampos Papagoras, Andreas Goules, Christina Katsiari, Dimitrios Vassilopoulos, Prodromos Sidiropoulos, Kyriaki A Boki, Petros P Sfikakis, George Liapis, Harikleia Gakiopoulou, Paraskevi Vasileios Voulgari, Dimitrios T Boumpas, George K Bertsias, Maria G G Tektonidou, Antonis Fanouriakis
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study. RMD open 10 (3) (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international (2024)
Antonis Fanouriakis, George K Bertsias, Dimitrios T Boumpas
Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al . Annals of the rheumatic diseases (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases (2024)
Chrysoula G Gialouri, Aglaia Chalkia, Christos Koutsianas, Katerina Chavatza, Evangelia Argyriou, Alexandros Panagiotopoulos, Anastasios Karmanakos, Aikaterini Dimouli, Christina Tsalapaki, Konstantinos Thomas, Philippos Orfanos, Pagona Lagiou, George Katsikas, Kyriaki Boki, Dimitrios T Boumpas, Dimitrios Petras, Dimitrios Vassilopoulos
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study. Rheumatology (Oxford, England) (2024)
Antonis Fanouriakis, Myrto Kostopoulou, George K Bertsias, Dimitrios T Boumpas
Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al . Annals of the rheumatic diseases (2024)
Eleni Zervopoulou, Maria Grigoriou, Stavros A Doumas, Danae Yiannakou, Pavlos Pavlidis, Gilles Gasparoni, Jörn Walter, Anastasia Filia, Harikleia Gakiopoulou, Aggelos Banos, Ioannis Mitroulis, Dimitrios T Boumpas
Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis. Lupus science & medicine 11 (1) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
Dionysis S Nikolopoulos, Catherine Loukogiannaki, George Sentis, Panagiotis Garantziotis, Theodora Manolakou, Noemin Kapsala, Myrto Nikoloudaki, Antigone Pieta, Sofia Flouda, Ioannis Parodis, George K Bertsias, Antonis Fanouriakis, Anastasia Filia, Dimitrios T Boumpas
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Annals of the rheumatic diseases 83 (9) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
Spyridon Katechis, Dionysis S Nikolopoulos, Sofia Flouda, Christina Adamichou, Katerina Chavatza, Noemin Kapsala, Pelagia Katsimbri, George K Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis
Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation. Rheumatology (Oxford, England) (2024)
Dionysis S Nikolopoulos, Theodora Manolakou, Alexia Polissidis, Anastasia Filia, George Bertsias, Yassemi Koutmani, Dimitrios T Boumpas
Microglia activation in the presence of intact blood-brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus. Annals of the rheumatic diseases (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Rönnblom, Marjan A Versnel, Edward M Vital
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice. Annals of the rheumatic diseases (2023)
Alexandros Panagiotopoulos, Konstantinos Thomas, Evangelia Argyriou, Aglaia Chalkia, Noemin Kapsala, Christos Koutsianas, Evgenia Mavrea, Dimitrios Petras, Dimitrios T Boumpas, Dimitrios Vassilopoulos
Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative study. Rheumatology (Oxford, England) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Konstantinos Thomas, Georgios Tsioulos, Christina Kotsogianni, Agellos Banos, Julie E Niemela, Aristine Cheng, Tom DiMaggio, Steven Holland, Sergio D Rosenzweig, Nikolaos Tziolos, Antonios Papadopoulos, Michail S Lionakis, Dimitrios T Boumpas
NF-kappa-B essential modulator (NEMO) gene polymorphism in an adult woman with systemic lupus erythematosus and recurrent non-tuberculous mycobacterial disseminated infections. RMD open 9 (2) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang-Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard A Furie, Dafna D Gladman, Frederic A Houssiau, Luís Sousa Inês, David R W Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F Morand, Gabriella Moroni, Marta Mosca, Johanna Mucke, Chetan B Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José M Pego-Reigosa, Michelle A Petri, Bernardo A Pons-Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G G Tektonidou, Y K Onno Teng, Angela Tincani, Edward M Vital, Ronald F Van Vollenhoven, Chris Wincup, George K Bertsias, Dimitrios T Boumpas
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the rheumatic diseases (2023)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy. Annals of the rheumatic diseases (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy. Annals of the rheumatic diseases (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy. Annals of the rheumatic diseases 82 (6) (2023)
Anastasia Pentari, Nicholas Simos, George Tzagarakis, Antonios Kagialis, George K Bertsias, Eleftherios Kavroulakis, Eirini Gratsia, Prodromos Sidiropoulos, Dimitrios T Boumpas, Efrosini Papadaki
Altered hippocampal connectivity dynamics predicts memory performance in neuropsychiatric lupus: a resting-state fMRI study using cross-recurrence quantification analysis. Lupus science & medicine 10 (2) (2023)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy. Annals of the rheumatic diseases 82 (6) (2023)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy. Annals of the rheumatic diseases (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Konstantinos Thomas, Georgios Tsioulos, Christina Kotsogianni, Agellos Banos, Julie E Niemela, Aristine Cheng, Tom DiMaggio, Steven Holland, Sergio D Rosenzweig, Nikolaos Tziolos, Antonios Papadopoulos, Michail S Lionakis, Dimitrios T Boumpas
NF-kappa-B essential modulator (NEMO) gene polymorphism in an adult woman with systemic lupus erythematosus and recurrent non-tuberculous mycobacterial disseminated infections. RMD open 9 (2) (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Konstantinos Thomas, Georgios Tsioulos, Christina Kotsogianni, Agellos Banos, Julie E Niemela, Aristine Cheng, Tom DiMaggio, Steven Holland, Sergio D Rosenzweig, Nikolaos Tziolos, Antonios Papadopoulos, Michail S Lionakis, Dimitrios T Boumpas
NF-kappa-B essential modulator (NEMO) gene polymorphism in an adult woman with systemic lupus erythematosus and recurrent non-tuberculous mycobacterial disseminated infections. RMD open 9 (2) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy. Annals of the rheumatic diseases 82 (6) (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy. Annals of the rheumatic diseases 82 (6) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
George C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T Boumpas, Nina Brodin, Ian N Bruce, Miguel Angel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan B Mukhtyar, Manuel Ramos-Casals, Naveed Sattar, Karen Schreiber, Savinio Sciascia, Elisabet Svenungsson, Zoltán Szekanecz, Anne-Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre Voskuyl, Gary John Macfarlane, Michael M Ward, Michael T Nurmohamed, Maria G G Tektonidou
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Annals of the rheumatic diseases 81 (6) (2022)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Treatment of lupus: more options after a long wait. Annals of the rheumatic diseases 81 (6) (2022)
Ronald F Van Vollenhoven, George Bertsias, Andrea Doria, David Isenberg, Eric F Morand, Michelle A Petri, Bernardo A Pons-Estel, Anisur Rahman, Manuel Francisco Ugarte-Gil, Alexandre Voskuyl, Laurent Arnaud, Ian N Bruce, Ricard Cervera, Nathalie Costedoat-Chalumeau, Caroline Gordon, Frederic A Houssiau, Marta Mosca, Matthias Schneider, Michael M Ward, Graciela Alarcon, Martin Aringer, Anka Askenase, Sang-Cheol Bae, Hendrika Bootsma, Dimitrios T Boumpas, Hermine I Brunner, Ann Elaine Clarke, Cindy Coney, László Czirják, Thomas Dörner, Raquel Faria, Rebecca Fischer, Ruth Fritsch-Stork, Murat Inanc, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Helena Olesinska, Guillermo Pons-Estel, Juanita Romero-Diaz, Blanca Rubio, Yehuda Schoenfeld, Eloisa Bonfá, Josef Smolen, Y K Onno Teng, Angela Tincani, Michel W P Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P Werth, Elena Zakharhova, Cynthia Aranow
2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus science & medicine 8 (1) (2022)
Eleni Frangou, Panagiotis Garantziotis, Maria Grigoriou, Aggelos Banos, Dionysis S Nikolopoulos, Antigone Pieta, Stavros A Doumas, Antonis Fanouriakis, Aikaterini Hatzioannou, Theodora Manolakou, Themis Alissafi, Panayotis Verginis, Emmanouil Athanasiadis, Emmanouil Dermitzakis, George Bertsias, Anastasia Filia, Dimitrios T Boumpas
Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis. Annals of the rheumatic diseases 81 (10) (2022)
Theodora Manolakou, Dionysis S Nikolopoulos, Dimitrios Gkikas, Anastasia Filia, Martina K Samiotaki, George M Stamatakis, Antonis Fanouriakis, Panagiotis Politis, Aggelos Banos, Themis Alissafi, Panayotis Verginis, Dimitrios T Boumpas
ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus. Science advances 8 (43) (2022)
Katerina Chavatza, Myrto Kostopoulou, Dionysis S Nikolopoulos, Ourania Gioti, Konstantina Togia, Laura Andreoli, Martin Aringer, John Boletis, Andrea Doria, Frederic A Houssiau, David Jayne, Marta Mosca, Elisabet Svenungsson, Angela Tincani, George Bertsias, Antonis Fanouriakis, Dimitrios T Boumpas
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients. Annals of the rheumatic diseases 80 (9) (2021)
Antonis Fanouriakis, Nikolaos Tziolos, George Bertsias, Dimitrios T Boumpas
Response to: Correspondence on "Update on the diagnosis and management of systemic lupus erythematosus" by Fanouriakis et al. Annals of the rheumatic diseases (2021)
Martin Aringer, Ralph Brinks, Thomas Dörner, David Daikh, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen, David Jayne, R Cervera, Nathalie Costedoat-Chalumeau, Betty Diamond, Dafna D Gladman, Bevra Hahn, Falk Hiepe, Søren Jacobsen, Zsuzsanna H McMahan, Kirsten Lerstrøm, Elena Massarotti, Joseph McCune, Guillermo Ruiz-Irastorza, Jorge Sanchez-Guerrero, Matthias Schneider, Murray B Urowitz, George Bertsias, Bimba F Hoyer, Nicolai Leuchten, Gabriela Schmajuk, Chiara Tani, Sara K Tedeschi, Zahi Touma, Branimir Anic, Florence Assan, Tak Mao Chan, Ann Elaine Clarke, Mary K Crow, László Czirják, Andrea Doria, Winfried Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter M Izmirly, Michelle Jung, Gábor Kumánovics, Xavier Mariette, Ivan Padjen, José M Pego-Reigosa, Juanita Romero-Diaz, Íñigo Rúa-Figueroa, Raphaèle Seror, Georg H Stummvoll, Yoshiya Tanaka, Maria G G Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J Fritzler, Ray Naden, Karen Costenbader, Sindhu R Johnson
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Annals of the rheumatic diseases (2021)
Christina Adamichou, Irini Genitsaridi, Dionysis S Nikolopoulos, Myrto Nikoloudaki, Argyro Repa, Alessandra Bortoluzzi, Antonis Fanouriakis, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Annals of the rheumatic diseases (2021)
Dionysis S Nikolopoulos, Myrto Kostopoulou, Antigoni Pieta, Sofia Flouda, Katerina Chavatza, Aggelos Banos, John Boletis, Pelagia Katsimbri, Dimitrios T Boumpas, Antonis Fanouriakis
Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease. Lupus science & medicine 7 (1) (2021)
Myrto Kostopoulou, Antonis Fanouriakis, Kim Cheema, John Boletis, George Bertsias, David Jayne, Dimitrios T Boumpas
Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations. RMD open 6 (2) (2021)
Dionysis S Nikolopoulos, Dimitris Kitsos, Matilda Papathanasiou, Maria Chondrogianni, Aikaterini Theodorou, Panagiotis Garantziotis, Antigone Pieta, Triantafyllos Doskas, George K Bertsias, Konstantinos Voumvourakis, Dimitrios T Boumpas, Antonis Fanouriakis
Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort. Rheumatology (Oxford, England) 60 (9) (2021)
Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans-Joachim Anders, Martin Aringer, Ingeborg Bajema, John Boletis, Eleni Frangou, Frederic A Houssiau, Jane Hollis, Adexandre Karras, Francesca Marchiori, Stephen D Marks, Gabriella Moroni, Marta Mosca, Ioannis Parodis, Manuel Praga, Matthias Schneider, Josef S Smolen, Vladimir Tesar, Maria Trachana, Ronald F Van Vollenhoven, Alexandre E Voskuyl, Y K Onno Teng, Bernadette van Leew, George Bertsias, David Jayne, Dimitrios T Boumpas
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Annals of the rheumatic diseases 79 (6) (2020)
Antonis Fanouriakis, Nikolaos Tziolos, George K Bertsias, Dimitrios T Boumpas
Update οn the diagnosis and management of systemic lupus erythematosus. Annals of the rheumatic diseases 80 (1) (2020)
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or 'blood-dominant' lupus? Annals of the rheumatic diseases 79 (6) (2020)
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Response to: 'Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus' by Wu et al. Annals of the rheumatic diseases (2020)
Sindhu R Johnson, Ralph Brinks, Karen H Costenbader, David Daikh, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen, David Jayne, R Cervera, Nathalie Costedoat-Chalumeau, Betty Diamond, Dafna D Gladman, Bevra Hahn, Falk Hiepe, Søren Jacobsen, Zsuzsanna H McMahan, Kirsten Lerstrøm, Elena Massarotti, Joseph McCune, Guillermo Ruiz-Irastorza, Jorge Sanchez-Guerrero, Matthias Schneider, Murray B Urowitz, George Bertsias, Bimba F Hoyer, Nicolai Leuchten, Chiara Tani, Sara K Tedeschi, Zahi Touma, Gabriela Schmajuk, Branimir Anic, Florence Assan, Tak Mao Chan, Ann Elaine Clarke, Mary K Crow, László Czirják, Andrea Doria, Winfried B Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter M Izmirly, Michelle Jung, Gábor Kumánovics, Xavier Mariette, Ivan Padjen, José M Pego-Reigosa, Juanita Romero-Diaz, Íñigo Rúa-Figueroa, Raphaèle Seror, Georg H Stummvoll, Yoshiya Tanaka, Maria G G Tektonidou, Carlos Vasconcelos, Edward M Vital, D J Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J Fritzler, Ray Naden, Thomas Dörner, Martin Aringer
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Annals of the rheumatic diseases 79 (10) (2020)
Maria Grigoriou, Aggelos Banos, Anastasia Filia, Pavlos Pavlidis, Stavroula Giannouli, Vassiliki Karali, Dionysis Nikolopoulos, Antigone Pieta, George Bertsias, Panayotis Verginis, Ioannis Mitroulis, Dimitrios T Boumpas
Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus. Annals of the rheumatic diseases 79 (2) (2019)
Christina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, Alessandra Bortoluzzi, Antonis Fanouriakis, Emmanouil Papastefanakis, Eleni Kalogiannaki, Irini Gergianaki, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. Annals of the rheumatic diseases 79 (2) (2019)
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Response to: 'Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations' by Orsolini et al. Annals of the rheumatic diseases 79 (11) (2019)
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Response to: 'Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine' by Michaud et al. Annals of the rheumatic diseases 79 (10) (2019)
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Response to: 'Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus' by Rua-Figueroa and Erausquin. Annals of the rheumatic diseases 79 (10) (2019)
Sindhu R Johnson, Zsuzsanna H McMahan, David Daikh, Ricard Cervera, Nathalie Costedoat-Chalumeau, Dafna D Gladman, Bevra H Hahn, Falk Hiepe, Jorge Sánchez-Guerrero, Elena M Massarotti, Dimitrios T Boumpas, Karen H Costenbader, David R W Jayne, Thomas Dörner, Diane L Kamen, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Martin Aringer
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria. The Journal of rheumatology 46 (7) (2018)

Dimitrios T Boumpas.css-eqlu8i{font-size:small;padding-left:4px;} (Dimitrios Boumpas)

Publication Activity (10 Years)

Top Topics

Top Venues

Dimitrios T Boumpas (Dimitrios Boumpas)